U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 20 points on Monday.
Following the market opening Monday, the Dow traded up 0.07% to 36,272.54 while the NASDAQ fell 0.26% to 14,366.24. The S&P 500 also fell, dropping, 0.02% to 4,603.60.
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program.
Compugen shares jumped 204.1% to $2.22 on Tuesday.